0
SYS6010, epidermal growth factor receptor-targeting antibody-drug conjugate for advanced non-small cell lung cancer: A phase 1 trial. (linkinghub.elsevier.com)
Authors:
Li ZM
… Lu S
Journal:
Cancer Cell
Published:
2026-08-13
DOI:
https://doi.org/10.1016/j.ccell.2026.07.012
Comments
Login to comment.
No comments yet. Be the first!